From: High EpCAM expression is linked to proliferation and lauren classification in gastric cancer
EpCAM expression | |||||
---|---|---|---|---|---|
0 | 1+ | 2+ | 3+ | Σ | |
patients | 37 (23%) | 52 (32%) | 27 (17%) | 47 (29%) | 163 |
Primary tumor | |||||
pT1 | 3 (14%) | 10 (48%) | 4 (19%) | 4 (19%) | 21 |
pT2 | 22 (26%) | 25 (29%) | 15 (17%) | 24 (28%) | 86 |
pT3 | 10 (21%) | 13 (27%) | 7 (15%) | 18 (38%) | 48 |
pT4 | 2 (25%) | 4 (50%) | 1 (13%) | 1 (13%) | 8 |
Lymph node status | |||||
pN0 | 8 (20%) | 13 (32%) | 10 (24%) | 10 (24%) | 41 |
pN1 | 10 (19%) | 19 (35%) | 8 (15%) | 17 (31%) | 54 |
pN2 | 8 (29%) | 10 (36%) | 4 (14%) | 6 (21%) | 28 |
pN3 | 11 (28%) | 10 (26%) | 5 (13%) | 13 (33%) | 39 |
Tumor grade | |||||
G1 | 1 (50%) | 0 (0%) | 1 (50%) | 0 (0%) | 2 |
G2 | 5 (14%) | 11 (31%) | 8 (22%) | 12 (33%) | 36 |
G3 | 30 (25%) | 40 (33%) | 18 (15%) | 34 (28%) | 122 |
G4 | 1 (33%) | 1 (33%) | 0 (0%) | 1 (33%) | 3 |
Laurén classification | |||||
diffuse | 20 (33%) | 15 (25%) | 9 (15%) | 17 (28%) | 61 |
intestinal | 8 (13%) | 21 (34%) | 13 (21%) | 20 (32%) | 62 |
mixed | 7 (22%) | 12 (38%) | 4 (13%) | 9 (28%) | 32 |
not classified | 2 (25%) | 4 (50%) | 1 (13%) | 1 (13%) | 8 |